Anti-VEGF therapy in mRCC: differences between Asian and non-Asian patients
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anti-VEGF therapy in mRCC: differences between Asian and non-Asian patients
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 110, Issue 6, Pages 1433-1437
Publisher
Springer Nature
Online
2014-02-19
DOI
10.1038/bjc.2014.28
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- VEGFR1 single nucleotide polymorphisms associated with outcome in patients with metastatic renal cell carcinoma treated with sunitinib – a multicentric retrospective analysis
- (2013) Benoit Beuselinck et al. ACTA ONCOLOGICA
- VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib
- (2013) M Scartozzi et al. BRITISH JOURNAL OF CANCER
- Pharmacogenetic determinants associated with sunitinib-induced toxicity and ethnic difference in Korean metastatic renal cell carcinoma patients
- (2013) Hye Ryun Kim et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Management of sunitinib adverse events in renal cell carcinoma patients: The Asian experience
- (2012) Aiping ZHOU Asia-Pacific Journal of Clinical Oncology
- Exposure–response relationships in patients with metastatic renal cell carcinoma receiving sunitinib
- (2011) Alain Ravaud et al. ANTI-CANCER DRUGS
- Clinical Outcome and Prognostic Factors of Sorafenib in Japanese Patients with Advanced Renal Cell Carcinoma in General Clinical Practice
- (2011) G. Tanigawa et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Sunitinib for Asian Patients with Advanced Renal Cell Carcinoma: A Comparable Efficacy with Different Toxicity Profiles
- (2011) Hyo Song Kim et al. ONCOLOGY
- Overall Survival and Updated Results from a Phase II Study of Sunitinib in Japanese Patients with Metastatic Renal Cell Carcinoma
- (2010) Y. Tomita et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- The Efficacy and Safety of Sunitinib in Korean Patients with Advanced Renal Cell Carcinoma: High Incidence of Toxicity Leads to Frequent Dose Reduction
- (2010) C. Yoo et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Kidney Cancer Working Group Report
- (2010) S. Naito et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Efficacy of sorafenib on metastatic renal cell carcinoma in Asian patients: Results from a multicenter study
- (2009) Hailiang Zhang et al. BMC CANCER
- Relationship between exposure to sunitinib and efficacy and tolerability endpoints in patients with cancer: results of a pharmacokinetic/pharmacodynamic meta-analysis
- (2009) Brett E. Houk et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- 7118 An Asian subpopulation analysis of the safety and efficacy of sunitinib in metastatic renal cell carcinoma
- (2009) S. Lee et al. EJC SUPPLEMENTS
- A Phase II Study of Sunitinib in Japanese Patients with Metastatic Renal Cell Carcinoma: Insights into the Treatment, Efficacy and Safety
- (2009) H. Uemura et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma
- (2009) Robert J. Motzer et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study
- (2009) Daniel Y.C. Heng et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial
- (2009) Martin E Gore et al. LANCET ONCOLOGY
- Treatment Outcomes of Sunitinib Treatment in Advanced Renal Cell Carcinoma Patients: A Single Cancer Center Experience in Korea
- (2009) Min Hee Hong et al. Cancer Research and Treatment
- Cardiotoxicity associated with the cancer therapeutic agent sunitinib malate
- (2008) M. L. Telli et al. ANNALS OF ONCOLOGY
- Predictive factors for severe toxicity of sunitinib in unselected patients with advanced renal cell cancer
- (2008) A A M van der Veldt et al. BRITISH JOURNAL OF CANCER
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started